85-4782-73 [取扱停止]Ebola Virus-like Particles, Strain Ebola/H.SAP-wt/COD/2014/Boende-Lokolia, Recombinant 100ug 397637

※お見積書はカートで印刷できます

冷凍

特徴

  • Ebola structural proteins, nucleoprotein, glycoprotein and matrix protein are transiently expressed to form a particle, without the non-structural proteins or genome. The resultant particles are non-infectious. Electron microscopy shows that the VLPs are around 20nm by 1000nm long. A detailed description of the particles, together with results of EM, SDS-PAGE and MS analysis can be seen under the COA/SDS tab on this page. Ebola hemorrhagic fever (EHF) is a severe disease caused by several species of Ebolavirus (EBOV), in the family Filoviridae. Prior to 2007, four species of EBOV had been identified, with two (Zaire ebolavirus and Sudan ebolavirus) having caused significant disease outbreaks in humans. The presence of a fifth EBOV virus species, Bundibugyo ebolavirus (BEBOV) was identified after an outbreak of EHF in the Bundibugyo District of western Uganda in 2007. Outbreaks of EHF are associated with person-to-person transmission after the virus is introduced into humans from a zoonotic reservoir. During outbreaks the virus is commonly transmitted through direct contact with infected persons or their bodily fluids. The onset of EHF is associated with nonspecific signs and symptoms, including fever, myalgias, headache, abdominal pain, nausea, vomiting, and diarrhoea. In the later stages of disease, overt haemorrhage has been reported in up to 50% of cases. Ebola Virus-like particles offer researchers non-infectious material containing Ebola structural proteins in a particle format. The Zaire subtype of the Ebola virus family is currently the most important in relation to outbreaks of disease in humans.  This subtype has been responsible for the largest ever outbreak of EHF, which started in West Africa in 2014, and was finally declared over only in early 2016. The Boende-Lokolia strain was identified at the beginning of this outbreak in the villages of Boende and Lokolia in the Democratic Republic of Congo.
  • Source:Recombinant protein corresponding to Ebola/H.SAP-wt/COD/2014/Boende-Lokolia strain of Ebola Virus-like particles, composed of Nucleoprotein, Glycoprotein and Matrix proteins, expressed in HEK293 cells.
  • Storage and Stability:Aliquot to avoid repeated freezing and thawing and store at -70°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

仕様

  • Size:100ug
  • Source Antigen:Recombinant, HEK293 cells
  • Grade:Purified
  • Purity:~80% (SDS-PAGE)
  • Form:Supplied as a liquid in 20mM Tris-HCl, pH 8, 400mM sodium chloride, 10mM sodium citrate.
  • EU Commodity Code:30021019
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
85-4782-73
型番
397637
入り数
1個
標準価格
362,000円(税抜)
WEB価格
取扱停止
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る